This document provides guidance on troubleshooting issues with Cardiovascular Implantable Electronic Devices (CIEDs) in hospital rooms and cardiac care units. It discusses potential acute and chronic problems including loose connections, sensing issues due to lead maturation or inappropriate programming, and pacing issues from lead insulation breaks or conductor coil fractures. Four main problems are outlined - failure to capture, loss of output, oversensing, and undersensing. Troubleshooting tips are provided for addressing each issue. The key point emphasized is that pacemakers are designed to pace and sense cardiac signals effectively.
This document discusses indications for cardiac implantable electronic devices (CIEDs) such as pacemakers, cardiac resynchronization therapy (CRT), and implantable cardioverter defibrillators (ICDs) according to guidelines. It covers classifications of bradyarrhythmias and indications for pacing in various conditions such as persistent bradycardia. Indications for CRT and ICDs are also outlined based on left ventricular ejection fraction, heart failure class, and other factors. Current health insurance reimbursement policies in Taiwan for these devices are also summarized.
This document provides guidance on troubleshooting issues with Cardiovascular Implantable Electronic Devices (CIEDs) in hospital rooms and cardiac care units. It discusses potential acute and chronic problems including loose connections, sensing issues due to lead maturation or inappropriate programming, and pacing issues from lead insulation breaks or conductor coil fractures. Four main problems are outlined - failure to capture, loss of output, oversensing, and undersensing. Troubleshooting tips are provided for addressing each issue. The key point emphasized is that pacemakers are designed to pace and sense cardiac signals effectively.
This document discusses indications for cardiac implantable electronic devices (CIEDs) such as pacemakers, cardiac resynchronization therapy (CRT), and implantable cardioverter defibrillators (ICDs) according to guidelines. It covers classifications of bradyarrhythmias and indications for pacing in various conditions such as persistent bradycardia. Indications for CRT and ICDs are also outlined based on left ventricular ejection fraction, heart failure class, and other factors. Current health insurance reimbursement policies in Taiwan for these devices are also summarized.
1. The document discusses the basic principles and settings of cardiovascular implantable electronic devices (CIEDs), including pacemakers.
2. It covers topics such as pacing and sensing functions, parameters like lower and upper rates, pacing modes, and refractory and blanking periods.
3. The optimal settings aim to ensure cardiac pacing meets patients' needs while avoiding unnecessary pacing and maximizing battery longevity.
植入性心臟電子儀器地基本原理與設定
This document discusses the basic principles and settings of implantable cardiac electronic devices. It covers topics such as voltage, current, impedance, pacing modes, detection zones, cardioversion, defibrillation, anti-tachycardia pacing, and challenges in reducing inappropriate therapies. Key points include an overview of Ohm's Law and its application to pacemakers, examples of different pacing modes like VVI and DDD, considerations for programming detection zones and therapy levels in ICDs, and the use of ATP to terminate VT episodes.
This document describes equipment and settings used in electrophysiology (EP) studies. It lists various pieces of equipment including fluoroscopy units, recording systems, cardiac stimulators, ablation generators, 3D mapping systems, and intracardiac ultrasound units. It provides details on catheter types, positions, and settings for standard EP studies including studies of arrhythmias like supraventricular tachycardia. It also explains pacing protocols and techniques used in EP studies to evaluate conduction properties and induce arrhythmias.
The document provides an overview of basic ICD treatment and concepts, including the evolution of ICDs, device components, automated functions such as sensing, detection, and SVT discrimination, and troubleshooting. Key aspects of ICD systems like battery depletion, lead design, and programming are discussed at a high level.
Cardiac arrhythmia refers to any abnormal heart rhythm and can cause the heart rate to be too fast, too slow, or irregular. Common types include sinus tachycardia, ventricular tachycardia, sinus bradycardia, paroxysmal supraventricular tachycardia, atrial flutter, atrial fibrillation, premature atrial contractions, premature ventricular contractions, and nodal rhythm. Treatment depends on the specific arrhythmia but may include medications, cardioversion, pacemakers, ablation, or defibrillation.
This document summarizes different types of cardiac arrhythmias including tachyarrhythmias and ventricular tachycardia. It discusses the mechanisms, classifications, diagnoses and treatments of supraventricular tachycardia including atrial flutter, atrial fibrillation, AV nodal reentrant tachycardia and AV reentrant tachycardia. It also covers ventricular tachycardia mechanisms including triggered activity, enhanced automaticity and reentry. Management strategies for acute and long term treatment of these arrhythmias are provided including electrical cardioversion, antiarrhythmic drug therapy and catheter ablation procedures.
This document discusses pacemakers and their management during anesthesia. It begins by describing the components of the heart's conducting system and types of pacemakers. It then discusses indications for pacemakers and implantable cardioverter defibrillators. The key points regarding anesthetic management are to have the device interrogated preoperatively, monitor it closely intraoperatively, and avoid potential electromagnetic interference from devices like electrocautery or defibrillation. Regional anesthesia is usually safe but general anesthesia requires avoiding drugs that could interfere with pacemaker function.
Pacemakers are electronic devices that initiate heartbeats when the heart's intrinsic electrical system cannot generate an adequate heart rate. They are indicated for slow heart rates that cause hemodynamic compromise, such as sick sinus syndrome or heart block. Pacemakers have a pulse generator and pacing leads that are placed transvenously, usually in the right ventricle. They sense intrinsic cardiac activity and pace the heart if needed, with functions including sensing, pacing, and adjustable settings for rate, output, and sensitivity. Complications can include infection, arrhythmias, and loss of capture.
How to perform and interpret entrainment pacing BasicsBenjamin Jacob
This document provides information on entrainment pacing, including:
1) Entrainment pacing involves accelerating the rate of a tachycardia to a faster pacing rate and resuming the intrinsic tachycardia rate when pacing stops. It allows study of arrhythmia origins and pathways.
2) For entrainment to occur, there must be a gap in excitability during the tachycardia for a pacing stimulus to be delivered without terminating the arrhythmia.
3) Entrainment can be identified by constant fusion of paced and tachycardia complexes except the last paced beat, or progressive fusion at different pacing rates showing changing morphology from tachycardia to
Pci or throm or pi in stemi best strategy(apicon 09022019)-finalDr.Vinod Sharma
- Primary angioplasty, thrombolysis, and pharmaco-invasive therapy are strategies for reperfusion in STEMI patients.
- The optimal strategy depends on factors like time since symptom onset, mortality risk from STEMI, availability of a skilled PCI laboratory, and time required for transport.
- Minimizing total ischemic time is critical as myocardial necrosis increases significantly past 40 minutes from occlusion. Every 30 minute delay in reperfusion increases 1-year mortality by 8%.
1. The document discusses the basic principles and settings of cardiovascular implantable electronic devices (CIEDs), including pacemakers.
2. It covers topics such as pacing and sensing functions, parameters like lower and upper rates, pacing modes, and refractory and blanking periods.
3. The optimal settings aim to ensure cardiac pacing meets patients' needs while avoiding unnecessary pacing and maximizing battery longevity.
植入性心臟電子儀器地基本原理與設定
This document discusses the basic principles and settings of implantable cardiac electronic devices. It covers topics such as voltage, current, impedance, pacing modes, detection zones, cardioversion, defibrillation, anti-tachycardia pacing, and challenges in reducing inappropriate therapies. Key points include an overview of Ohm's Law and its application to pacemakers, examples of different pacing modes like VVI and DDD, considerations for programming detection zones and therapy levels in ICDs, and the use of ATP to terminate VT episodes.
This document describes equipment and settings used in electrophysiology (EP) studies. It lists various pieces of equipment including fluoroscopy units, recording systems, cardiac stimulators, ablation generators, 3D mapping systems, and intracardiac ultrasound units. It provides details on catheter types, positions, and settings for standard EP studies including studies of arrhythmias like supraventricular tachycardia. It also explains pacing protocols and techniques used in EP studies to evaluate conduction properties and induce arrhythmias.
The document provides an overview of basic ICD treatment and concepts, including the evolution of ICDs, device components, automated functions such as sensing, detection, and SVT discrimination, and troubleshooting. Key aspects of ICD systems like battery depletion, lead design, and programming are discussed at a high level.
Cardiac arrhythmia refers to any abnormal heart rhythm and can cause the heart rate to be too fast, too slow, or irregular. Common types include sinus tachycardia, ventricular tachycardia, sinus bradycardia, paroxysmal supraventricular tachycardia, atrial flutter, atrial fibrillation, premature atrial contractions, premature ventricular contractions, and nodal rhythm. Treatment depends on the specific arrhythmia but may include medications, cardioversion, pacemakers, ablation, or defibrillation.
This document summarizes different types of cardiac arrhythmias including tachyarrhythmias and ventricular tachycardia. It discusses the mechanisms, classifications, diagnoses and treatments of supraventricular tachycardia including atrial flutter, atrial fibrillation, AV nodal reentrant tachycardia and AV reentrant tachycardia. It also covers ventricular tachycardia mechanisms including triggered activity, enhanced automaticity and reentry. Management strategies for acute and long term treatment of these arrhythmias are provided including electrical cardioversion, antiarrhythmic drug therapy and catheter ablation procedures.
This document discusses pacemakers and their management during anesthesia. It begins by describing the components of the heart's conducting system and types of pacemakers. It then discusses indications for pacemakers and implantable cardioverter defibrillators. The key points regarding anesthetic management are to have the device interrogated preoperatively, monitor it closely intraoperatively, and avoid potential electromagnetic interference from devices like electrocautery or defibrillation. Regional anesthesia is usually safe but general anesthesia requires avoiding drugs that could interfere with pacemaker function.
Pacemakers are electronic devices that initiate heartbeats when the heart's intrinsic electrical system cannot generate an adequate heart rate. They are indicated for slow heart rates that cause hemodynamic compromise, such as sick sinus syndrome or heart block. Pacemakers have a pulse generator and pacing leads that are placed transvenously, usually in the right ventricle. They sense intrinsic cardiac activity and pace the heart if needed, with functions including sensing, pacing, and adjustable settings for rate, output, and sensitivity. Complications can include infection, arrhythmias, and loss of capture.
How to perform and interpret entrainment pacing BasicsBenjamin Jacob
This document provides information on entrainment pacing, including:
1) Entrainment pacing involves accelerating the rate of a tachycardia to a faster pacing rate and resuming the intrinsic tachycardia rate when pacing stops. It allows study of arrhythmia origins and pathways.
2) For entrainment to occur, there must be a gap in excitability during the tachycardia for a pacing stimulus to be delivered without terminating the arrhythmia.
3) Entrainment can be identified by constant fusion of paced and tachycardia complexes except the last paced beat, or progressive fusion at different pacing rates showing changing morphology from tachycardia to
Pci or throm or pi in stemi best strategy(apicon 09022019)-finalDr.Vinod Sharma
- Primary angioplasty, thrombolysis, and pharmaco-invasive therapy are strategies for reperfusion in STEMI patients.
- The optimal strategy depends on factors like time since symptom onset, mortality risk from STEMI, availability of a skilled PCI laboratory, and time required for transport.
- Minimizing total ischemic time is critical as myocardial necrosis increases significantly past 40 minutes from occlusion. Every 30 minute delay in reperfusion increases 1-year mortality by 8%.
1) The digital ESC Congress 2020 attracted over 116,000 healthcare professionals from 211 countries, focusing on new knowledge in arrhythmias and device therapy.
2) New guidelines and studies provided updates on atrial fibrillation screening and management, showing benefits of early rhythm control and new anticoagulants.
3) Studies explored new pacing approaches like His bundle and left bundle pacing to improve effectiveness and reduce fluoroscopy time.
A meeting was held on August 10, 2019 (Saturday) in room 803 of the Taipei Chang Yung-fa International Convention Center. The meeting location and date are provided.